Abingdon Health (LON:ABDX) Trading 4.8% Higher – Still a Buy?

Shares of Abingdon Health Plc (LON:ABDX) traded up 4.8% during mid-day trading on Thursday . The company traded as high as GBX 11 and last traded at GBX 11. 81,049 shares were traded during trading, a decline of 66% from the average session volume of 238,041 shares. The stock had previously closed at GBX 10.50.

Abingdon Health Price Performance

The stock has a market capitalization of £27.80 million, a P/E ratio of -13.58 and a beta of 0.13. The business has a fifty day simple moving average of GBX 10.45 and a 200 day simple moving average of GBX 10.13. The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.